Change - Announcement of Appointment::Appointment of Non-Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
HEALTHWAY MEDICAL CORPORATION LIMITED
Securities
HEALTHWAY MEDICAL CORP LTD - SG1X09940682 - 5NG
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
03-Jun-2022 17:56:01
Status
New
Announcement Sub Title
Appointment of Non-Independent Non-Executive Director
Announcement Reference
SG220603OTHRNRRI
Submitted By (Co./ Ind. Name)
Chew Pei Tsing
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Non-Independent Non-Executive Director

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Date Of Appointment
01/07/2022
Name Of Person
Khor Chin Kee
Age
60
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Nominating Committee and the Board of Directors ("Board"), having considered the qualification, experience and suitability of Dr. Khor, is satisfied that Dr. Khor possesses the requisite qualifications and work experience for the position of a Director. Dr. Khor brings a wealth of experience after taking various senior positions in the healthcare sector in Singapore including the position of the Company's Chief Executive Officer between 1 June 2018 and 30 June 2022. On the recommendation by the Nominating Committee, the Board approved the appointment of Dr. Khor as a Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Independent Non-Executive Director
Professional qualifications
Degrees of Bachelor of Medicine and Bachelor of Surgery, The National University of Singapore
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
1 June 2018 - Current
Chief Executive Officer, Healthway Medical Corporation Limited

1 June 2018 - Current
Advisor, FWD Singapore

November 2017 - 31 May 2018
Senior Medical Advisor, Healthway Medical Corporation Limited

2016 - 31 May 2018
Medical Director, FWD Singapore

2013 - 2015
CEO, Parkway Shenton Ltd
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct interest of 2,000,000 shares and deemed interest of 10,260 shares held by his wife, Dr. Chong Bick Yew
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Claas Medical Centre Pte. Ltd.
BCNG Holdings Pte. Ltd.
Without Borders Pte. Ltd.
Present
Healthway Dental Pte. Ltd.
Healthway Medical Group Pte Ltd
Healthway Medical Enterprises Pte Ltd
Island Orthopaedic Consultants Pte Ltd
Vista Medicare Pte. Ltd.
Silver Cross Healthcare Pte Ltd
Unimedic Pte. Ltd.
EBH Cpital Pte. Ltd.
UCare.IO Pte. Ltd.
SBCC Clinic Pte Ltd
SBCC Women's Clinic Pte. Ltd.
Mednefits Pte. Ltd.
Mednefits Singapore Pte. Ltd.
Mednefits Holdings Pte. Ltd.
The Clinic @ One George Street Pte. Ltd.
The Clinic @ Campus Pte. Ltd.
The Clinic @ Fusionopolis Pte. Ltd.
The Clinic @ Aperia Pte. Ltd.
The Clinic @ Capitagreen Pte. Ltd.
The Clinic @ Businss City Pte. Ltd.
The Clinic @ Tai Seng Pte. Ltd.
The Clinic @ Marina One Pte. Ltd.
The Clinc @ HF Pte. Ltd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
Yes
If Yes, Please provide full details
Dr. Khor has been the Chief Executive Officer of Healthway Medical Corporation Limited (the "Company") since 1 June 2018.

The Company had received enquiries and communicated with the Singapore Exchange Regulation Pte. Ltd. in relation to its obligations under Catalist Listing Rule 703(4)(a) read with paragraph 27(a) of the Corporate Disclosure Policy. This arose from certain inaccurate disclosures in the Company's annual report for the financial year ended 31 December 2019 ("AR 2019") pertaining to the re-election of Mr. Sin Boon Ann and the appointment of Ms. Poh Mui Hoon. The AR 2019 had been announced on the SGXNet on 15 April 2020 and the aforesaid disclosures were subsequently revised and corrected by way of a corrigendum to the AR2019 announced on the SGXNet on 22 June 2020.
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
AsiaMedic Limited

2 July 2007 - 1 April 2010
Chief Executive Officer and Executive Director

21 September 2010 - 20 April 2013
Non-Independent Non-Executive Director
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable